Home » Newsletters » BioWorld Science

BioWorld Science

May 27, 1997

View Archived Issues

Glaxo Wellcome discloses heteroaromatic protein tyrosine kinase inhibitors

Short-acting beta1-adrenoceptor blockers from U. of Melbourne

ET antagonists disclosed by Merck KGaA

Microcide reveals new cephalosporins active against resistant organisms

Opioid antagonists/agonists described by Toray

Banyu discovers potent new antitumor agent

Natural antitumor compounds described by Banyu

Inhibitors of 5alpha-reductase from Kyowa Hakko

Antiviral pyrimidine nucleosides described by Yamasa

Prodrugs of nitrogen mustard with selective antitumor activity

MP-52 to be developed worldwide by HMR

NDA to be submitted in Japan for nevirapine

Glaxo to submit NDA in Japan for lamivudine in hepatitis

Tamsulosin cleared by FDA

Protease inhibitors in Japan

PharmaSciences and BTG extend license for hydrogel drug delivery technology

Fujisawa and Solvay sign marketing agreement for antidepressant

IDEC Pharmaceuticals: Q1 1997 highlights

Novel antiinflammatory agent from Parke-Davis

Sano: Q1 1997 highlights

Neutralase effective for heparin reversal in CAB

GalaGen: Q1 1997 highlights

OXiGENE: Q1 1997 highlights

Algos: Q1 1997 highlights

BY-963 for delineation of myocardial perfusion during cardiac surgery

Clevidipine for controlling hypertension after CABG

Favorable hemodynamic profile of aptiganel during general anesthesia

Popular Stories

23andme founder-led group outbids Regeneron for company
BioWorld
The 23andme Holding Co.’s saga came full circle with founder Anne Wojcicki regaining control of the bankrupt genetic testing company in a bidding battle against...
Today's news in brief
BioWorld
BioWorld briefs for June 18, 2025.
Elevidys’ second liver death hits Sarepta, sends DMD ripples
BioWorld
How the U.S. FDA might respond became a serious question for Wall Street as Sarepta Therapeutics Inc. made known a second death due to acute liver failure with...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for June 18, 2025.
EACR 2025: Immune rewiring in cancer orchestrates tumor microenvironment
BioWorld Science
Among the presentations included in the Top Abstracts category at the recently inaugurated Annual Congress of the European Association for Cancer Research (EACR)...